These emerging treatments, Tirzepatide , represent a remarkable advancement in managing obesity and possibly associated conditions . They are grouped as GLP-1 hormone agonists , meaning they to replicate the endogenous GLP-1 hormone , boosting insulin secretion and suppressing hunger . Although Semaglutide every functions largely similarly, these m